Sugihiratake mushroom (Angel's Wing Mushroom)-induced cryptogenic encephalopathy may involve vitamin D analogues

23Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

In autumn 2004, many Japanese patients with renal failure developed cryptogenic encephalopathy by consuming sugihiratake mushroom, a Japanese delicacy. To elucidate the relationship between the cryptogenic cases and this mushroom, we conducted a multivariate analysis of metabolites in 'Probably Toxic' sugihiratake collected from the area of encephalopathy outbreaks, and 'Probably Safe' sugihiratake collected from unaffected areas using UPLC/ToF MS. The results indicate that the presence of milligram quantities of vitamin D-like compounds per 10 g of dried sugihiratake from the areas of encephalopathy outbreaks. Two hypotheses to induce the encephalopathy are proposed: the found metabolites are (1) vitamin D agonists, which induce acute and severe hypercalcemia and/or hyperammonemia and/or vitamin D toxicity, or (2) vitamin D antagonists, which induce acute and severe hypocalcemia. © 2006 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Sasaki, H., Akiyama, H., Yoshida, Y., Kondo, K., Amakura, Y., Kasahara, Y., & Maitani, T. (2006). Sugihiratake mushroom (Angel’s Wing Mushroom)-induced cryptogenic encephalopathy may involve vitamin D analogues. Biological and Pharmaceutical Bulletin, 29(12), 2514–2518. https://doi.org/10.1248/bpb.29.2514

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free